Case study knowledge base.
Evolving safe & effective human experimental therapies.
Neurotherapies for electrochemical and neuroelectrophysiological imbalances — Bespoke multipotent configurations selectively administered to target CNS regions below the corpus callosum to stabilise sensitivity, central pain syndrome, comprehension / access to memory, induced GABA neuroprotection, left-right brain transitions, hormonal imbalances and insomnia
Off medication / tapering / in withdrawal / post withdrawal
Age group 16 to 60 years